RxDoctor Payments Data

Stephanie Godfrey

Family · Lindon, UTNPI 1750707030

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $309,620 of the $358,331 with a category attached, or 86.4%. AbbVie accounts for 99.9% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $124,267 and has fallen 64.6% since, to $43,971 in 2025. Among family clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$358,331in general payments, 2019–2025

Across 672 payments — averaging $533.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$358K
  • Galderma Laboratories, L.p.$242
  • Merz North America, Inc.$150
  • Arteriocyte Medical Systems, Inc.$31
  • Revance Therapeutics, Inc.$29

What the payments were for

  • Consulting fees$4,5681%
  • Speaking & faculty fees$309,62086%
  • Travel & lodging$34,92510%
  • Food & beverage$9,0903%
  • Education$1280%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$358,331 in reported general payments places this provider in the 95th percentile of 1,460 family providers in Utah.

See all family providers in Utah

Other family in Lindon

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →